Cargando…
Practice-Based Evidence: Profiling the Safety of Cilostazol by Text-Mining of Clinical Notes
BACKGROUND: Peripheral arterial disease (PAD) is a growing problem with few available therapies. Cilostazol is the only FDA-approved medication with a class I indication for intermittent claudication, but carries a black box warning due to concerns for increased cardiovascular mortality. To assess t...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662653/ https://www.ncbi.nlm.nih.gov/pubmed/23717437 http://dx.doi.org/10.1371/journal.pone.0063499 |